Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including

Bangkok, November 20, 2015 ? The 10th SEC Working Papers Forum today has revealed the results of three research studies on the common theme, ?Investment: Expectations and Reality,? conducted by the

P.T. Research Co., Ltd. P.T. Research Co., Ltd. operated derivatives business without license or registration with the SEC in violation of Section 16 of the Derivatives Act B.E. 2546 (2003). This

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

, Bangkok on 24 November 2020. SEC Chairman Pichit Akaratit noted: “Research is a process of creating new knowledge, enabling development and innovation. Research is, therefore, an important mechanism for

enhancement for investment analysts and research, as well as securities professionals to build investor confidence and strengthen business competitiveness. The meeting also discussed certain business obstacles

Business Development and Operations at Morningstar Research (Thailand) Co., Ltd., shared insights on the ESG risks of Thailand’s fund industry. The event also provided an opportunity for fund managers to

event, the SEC made a charitable donation to the "Pranangklao Hospital Foundation" to help underprivileged patients and promote medical research, at the NACC Office on 17 November 2023.

Mr. Pat Thamma Mr. Pat Thamma, director of P.T. Research Co., Ltd., operated derivatives business without license or registration with the SEC in violation of Section 16 of the Derivatives Act B.E

involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause